ARCHIVES

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

Bourne Tells ACCC White House Backs Hospice Concept

May 12, 1978

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998